Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Scott

Showing results (51-60 of 395) with videos related to

Pageof 40
Sort By:
Expert Review of Anticancer Therapy|October 5, 2016
Targeting the vasculature: anti-angiogenic agents for malignant mesotheliomaPuey Ling Chia, Prudence A Russell, Andrew M Scott, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 17, 2007
Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practiceNathan Lawrentschuk, Ian D Davis, Damien M Bolton, et al.
Cancer Research|November 12, 2020
Eph Receptors in the Immunosuppressive Tumor MicroenvironmentPeter W Janes, Mary E Vail, Matthias Ernst, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 7, 2025
Tracing the global evolution of PSMA-targeted radioligand therapy in prostate cancer: clinical advancements, future directions, and challengesGaia Ninatti, Akram Al-Ibraheem, Sze T Lee, et al.
BJU International|April 29, 2006
Positron emission tomography and molecular imaging of the prostate: an updateNathan Lawrentschuk, Ian D Davis, Damien M Bolton, et al.
Nature Reviews. Urology|May 8, 2010
Functional imaging of renal cell carcinomaNathan Lawrentschuk, Ian D Davis, Damien M Bolton, et al.
BJU International|April 29, 2006
Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationshipNathan Lawrentschuk, Ian D Davis, Damien M Bolton, et al.
World Journal of Nuclear Medicine|July 24, 2018
Metastatic clear cell renal cell carcinoma demonstrating intense uptake on <sup>68</sup>Ga-DOTATATE positron emission tomography: Three case reports and a review of the literatureDavid P Nadebaum, Sze Ting Lee, Mehrdad Nikfarjam, et al.
Expert Opinion on Drug Delivery|December 15, 2015
Antibody-mediated delivery of therapeutics for cancer therapySagun Parakh, Adam C Parslow, Hui K Gan, et al.
Expert Review of Anticancer Therapy|September 28, 2020
New insights into ErbB3 function and therapeutic targeting in cancerUmbreen Hafeez, Adam C Parslow, Hui K Gan, et al.
Pageof 40

Showing results (51-60 of 395) with videos related to

Sort By:
Pageof 40
Expert Review of Anticancer Therapy|October 5, 2016
Targeting the vasculature: anti-angiogenic agents for malignant mesotheliomaPuey Ling Chia, Prudence A Russell, Andrew M Scott, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 17, 2007
Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practiceNathan Lawrentschuk, Ian D Davis, Damien M Bolton, et al.
Cancer Research|November 12, 2020
Eph Receptors in the Immunosuppressive Tumor MicroenvironmentPeter W Janes, Mary E Vail, Matthias Ernst, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 7, 2025
Tracing the global evolution of PSMA-targeted radioligand therapy in prostate cancer: clinical advancements, future directions, and challengesGaia Ninatti, Akram Al-Ibraheem, Sze T Lee, et al.
BJU International|April 29, 2006
Positron emission tomography and molecular imaging of the prostate: an updateNathan Lawrentschuk, Ian D Davis, Damien M Bolton, et al.
Nature Reviews. Urology|May 8, 2010
Functional imaging of renal cell carcinomaNathan Lawrentschuk, Ian D Davis, Damien M Bolton, et al.
BJU International|April 29, 2006
Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationshipNathan Lawrentschuk, Ian D Davis, Damien M Bolton, et al.
World Journal of Nuclear Medicine|July 24, 2018
Metastatic clear cell renal cell carcinoma demonstrating intense uptake on <sup>68</sup>Ga-DOTATATE positron emission tomography: Three case reports and a review of the literatureDavid P Nadebaum, Sze Ting Lee, Mehrdad Nikfarjam, et al.
Expert Opinion on Drug Delivery|December 15, 2015
Antibody-mediated delivery of therapeutics for cancer therapySagun Parakh, Adam C Parslow, Hui K Gan, et al.
Expert Review of Anticancer Therapy|September 28, 2020
New insights into ErbB3 function and therapeutic targeting in cancerUmbreen Hafeez, Adam C Parslow, Hui K Gan, et al.
Pageof 40